Whitfield Advises Altaris on Acquisition of Clarivate's Life Sciences & Healthcare Business

Press Release   ·   06 July 2026

Overview

Altaris agreed to buy Clarivate's Life Sciences & Healthcare operation for an aggregate $600 million, according to the source announcement about the business separation.

Consideration components

The reported price comprised $500 million cash at closing, $25 million deferred and a $75 million unsecured senior note, subject to adjustments.

Business perimeter

The Cortellis and Decision Resources Group portfolios would operate independently under Altaris ownership after completion.

Conditions and advisers

Closing was expected in the second half of 2026, subject to approvals. Laura Sullivan and Heath Mayo are among the corporate advisers named, with technology, finance and tax teams also credited.